title: ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.
abstract: In the follow-up of Hodgkin's lymphoma patients, the focus in the first 5 years is to detect recurrence, while after 5 years, the focus is on limiting and detecting late effects of treatment. In the first 5 years post-treatment, routine history and physical and computed tomography (CT) imaging (more frequent in the first 2 years) are generally appropriate. However, there are limited data to support the role of positron emission tomography scanning as routine follow-up. Beyond 5 years post-treatment, annual history and physical is appropriate, although there is no longer a role for routine imaging for recurrences. Women irradiated to the chest area at a young age (<35) would benefit from annual mammogram screening given the increased breast cancer risk. Magnetic resonance imaging can be considered, although there is a lack of data supporting its role in this population. Low-dose chest CT for lung cancer screening in patients with history of mediastinal irradiation and/or alkylating chemotherapy exposures and a smoking history can be considered, although data on its utility is lacking. Cardiac screening with echocardiogram and exercise tolerance tests in patients with history of mediastinal irradiation and/or adriamycin exposure may be appropriate, although the optimal screening interval would depend on mediastinal dose, adriamycin dose, presence of other cardiac risk factors and findings at the baseline screening. Patients at risk for cardiac disease due to treatment exposure would also benefit from lipid screening every 1-3 years.
authors.forename: Andrea
authors.initials: A
authors.lastname: Ng
authors.forename: Louis S
authors.initials: LS
authors.lastname: Constine
authors.forename: Ranjan
authors.initials: R
authors.lastname: Advani
authors.forename: Prajnan
authors.initials: P
authors.lastname: Das
authors.forename: Christopher
authors.initials: C
authors.lastname: Flowers
authors.forename: Jonathan
authors.initials: J
authors.lastname: Friedberg
authors.forename: David C
authors.initials: DC
authors.lastname: Hodgson
authors.forename: Cindy L
authors.initials: CL
authors.lastname: Schwartz
authors.forename: Richard B
authors.initials: RB
authors.lastname: Wilder
authors.forename: Lynn D
authors.initials: LD
authors.lastname: Wilson
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Yunes
mesh_terms: D003131:Combined Modality Therapy; D003952:Diagnostic Imaging; D005260:Female; D005500:Follow-Up Studies; D019983:Guideline Adherence; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D016609:Neoplasms, Second Primary / Q000175:diagnosis*; D017410:Practice Guidelines as Topic; D015996:Survival Rate